PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
TI  - Randomized, Prospective Trial of Customized Neoadjuvant versus Standard Chemotherapy Gets Underway
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 14--14
VI  - 14
IP  - 3
4099  - http://mdc.sagepub.com/content/14/3/14.short
4100  - http://mdc.sagepub.com/content/14/3/14.full
AB  - The first prospective, multicenter, randomized Phase 2 study to test the use of customized chemotherapy (CT) in locally advanced stage IIIA (N2) non—small cell lung cancer (NSCLC) is currently recruiting patients. The rationale and design of the Customized Neoadjuvant Versus Standard Chemotherapy in NSCLC Patients With Resectable Stage IIIA (N2) Disease trial [CONTEST; NCT01784549] were presented in a poster session.